Skip to main content
Screener/Healthcare/Biotechnology

HRTX — Heron Therapeutics, Inc.

NASDAQ
$0.51-0.32 (-38.33%)
Micro CapPenny StockUnder $1Under $5Healthcare
$0.74
$2.30
$0.50
$0.69
EPS (TTM)$-0.18
P/E Ratio-9.99
Dividend Yield—
Market Cap$144.4M
Volume12.77M
Prev Close$0.83
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$34.7M-$8.1M$-0.0469.4%-23.4%
Q4 '25$40.6M-$3.0M$-0.0281.2%-7.3%
Q3 '25$38.2M-$17.5M$-0.1059.7%-45.8%
Q2 '25$37.2M-$2.4M$-0.0273.5%-6.4%
Q1 '25$38.9M$2.6M$0.0278.3%6.8%
Q4 '24$40.8M$3.7M$0.0274.9%9.0%
Q3 '24$32.8M-$4.8M$-0.0371.2%-14.8%
Q2 '24$36.0M-$9.2M$-0.0670.8%-25.6%
Get Your Daily Market Recap